v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,194,424 $ 1,112,642
Prepaid expenses and other current assets 676,820 468,792
Inventories 3,491,513 3,781,837
Advances on contracts 1,411,785 1,408,395
Total current assets 7,352,645 7,477,834
Furniture, fixtures and equipment, net 18,474 19,193
Intangibles, net 61,960 79,063
Right of use assets finance lease 51,255 55,811
Right of use assets operating lease 121,799 150,378
Deferred financing costs 332,671
Other assets 24,150 24,150
Total assets 7,962,954 7,806,429
Current liabilities:    
Current portion of finance lease liabilities 30,753 27,347
Current portion of operating lease liabilities 134,093 130,355
Total current liabilities 4,857,520 4,131,262
Non-current portion of finance lease liabilities 20,502 27,336
Non-current portion of operating lease liabilities 35,208
Convertible notes payable, related parties 800,000 800,000
Total liabilities 5,678,022 4,993,806
Commitments and contingencies  
Stockholders’ equity    
Common stock, par value $0.001; authorized 125,000,000 shares; 80,486,449 shares issued and 80,453,116 shares outstanding as of March 31, 2026; 80,486,449 shares issued and 80,453,116 shares outstanding as of December 31, 2025; 80,487 80,487
Additional paid in capital 137,731,136 137,418,974
Accumulated deficit (134,615,175) (133,775,322)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific Inc. stockholders’ equity 2,284,932 2,812,623
Total liabilities and stockholders’ equity 7,962,954 7,806,429
Nonrelated Party [Member]    
Current assets:    
Accounts receivable 555,766 680,620
Current liabilities:    
Accounts payable 2,269,296 1,430,250
Accrued expenses 1,053,535 995,206
Related Party [Member]    
Current assets:    
Accounts receivable 22,337 25,548
Current liabilities:    
Accounts payable 992,874 1,359,698
Accrued expenses $ 376,969 $ 188,406